Latest News and Press Releases
Want to stay updated on the latest news?
-
PHILADELPHIA and OXFORD, United Kingdom, March 02, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that James Noble,...
-
GUANGZHOU, China, March 02, 2017 (GLOBE NEWSWIRE) -- YY Inc. (NASDAQ:YY) ("YY" or the “Company”), a live streaming platform, today announced that it plans to release its fourth quarter and full year...
-
STAMFORD, Conn., March 02, 2017 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to...
-
NEW YORK, March 02, 2017 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (OTCQB:TYMI), a specialty biotechnology company developing cancer therapeutics targeted at multiple tumor types, today announced...
-
WIXOM, Mich., March 02, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney...
-
Company Signs Lease Amendment to Reduce Corporate HeadquartersRenews Multi-Year Martha Stewart Partnership with Macy’sSigns New Martha Stewart Crafts Partnership with Michaels Q4 Revenue increased 44%...
-
Expects full year revenues to grow from approximately $13 million in 2016 to over $18 million in 2017 Will be presenting and webcasting to investors at the Roth Conference on March 13 at...
-
TEL AVIV, Israel, March 02, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...
-
BELLEVILLE, Wis., March 02, 2017 (GLOBE NEWSWIRE) -- Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading”) (NASDAQ:DLTH), a lifestyle brand of men’s and women’s casual wear, workwear...
-
Five Months of Continuous Full Production at Geismar Biorefinery,Full Ownership of European Assets, Surpasses Two Billion Gallons Sold NOTE: Videos on these topics can be viewed at...